Consumers are on board, with an estimated 26% of U.S. adults planning to take a weight loss drug in 2025, according to ...

Discover the strengths & weaknesses of healthcare giants Johnson & Johnson and Pfizer. Find out which stock is more promising ...

U.S. President Donald Trump has issued a memorandum directing federal agencies to restrict inbound and outbound investments ...

Corporate America is scrambling to implement countermeasures as President Donald Trump's latest tariffs on Chinese imports ...

Novo Nordisk (NVO), the maker of the popular diabetes and weight-loss drugs Ozempic and Wegovy, expects at least some ...

Experts have warned that additional levies will only serve to push up prices in the already costly U.S. healthcare sector.

Trump looks forward to such things, but he has made the situation quite complicated for the citizens of his country.

Trade groups are urging the administration to consider the impact on patient care and are pushing for exemptions to the tariffs. Also in the news: Pfizer might move production to the U.S. to combat ...

Pfizer reacts to Donald Trump’s tariff threats on big pharma, another regulatory meeting is canceled under RFK Jr., AbbVie ...

We recently compiled a list of the Jim Cramer Discusses These 11 Stocks & Shares ChatGPT’s Flaws. In this article, we are ...

President Donald Trump’s 25% tariffs on imports from Mexico and Canada took effect Tuesday, and while many industries are ...

Pfizer (PFE) may move overseas manufacturing to its existing plants in the U.S., if required, as the Trump administration threatens numerous ...